Kevin Lalande

Lyric Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company. The firm develops novel gastrointestinal therapeutics for unmet medical needs in the hospital settings. The company was founded by David Wurtman and M. Scott Harris in 2013 and is headquartered in South San Fancisco, CA.

Part of Motorola Solutions, Inc., Serus LLC is a company that develops Java-based Web site development and Web page editing technologies. The company is based in Provo, UT. The company was founded by Kevin Myles Lalande. Serus was acquired by Netopia, Inc. on December 18, 1998 for $7.12 million.

Part of Mindpix Corp., TimeMarker, Inc. develops wireless Internet exchange technology. The company is based in Salt Lake City, UT. The company was founded by Kevin Myles Lalande, Mark Hendricks. TimeMarker was acquired by PrimeHoldings.com, Inc. on July 10, 2001.

SHVMS, LLC (Sante Ventures) is a Venture Capital firm founded in 2006 by Joe Hal Cunningham, Kevin Myles Lalande and Doug Dewitt French. The firm is headquartered in Austin, Texas.

AVP Management Services, Inc. (AVP Management Services) is a private equity/venture capital firm firm founded in 1979 by Joseph Charles Aragona, Ken Paul DeAngelis and Jeff C. Garvey. The firm is headquartered in Austin, Texas.

Molecular Templates, Inc. operates as a holding company that engages in the discovery and development of immunotoxins for the treatment of cancer and other serious diseases. These are capable of targeting validated therapeutic cell surface receptors but also non-traditional targets that cannot be therapeutically targeted by antibodies or small molecules. Its product pipeline consists of lead candidates for non-Hodgkin's lymphoma, multiple myeloma, and breast cancer. The company was founded by Jean Gariépy and Leigh Revers in 2009 and is headquartered in Georgetown, TX.

Terapio Corp. develops therapeutics based on the RLIP76 protein. The firm’s products are used in the areas of radiation countermeasure, chemical countermeasure and oncology supportive care. The company was founded by Casey Cunningham, Kevin Lalande and Sanjay Awasthi in 2005 and is headquartered in Austin, TX.

Laguna Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. Its lead product, Vanoxerine is a therapeutic candidate being developed for treatment of atrial fibrillation and atrial flutter. The firm’s product is a potential pharmaceutical option to rapidly terminate atrial fibrillation in both hospital and home settings. The company was founded in 2006 by Arthur M. Brown and Howard C. Dittrich and is headquartered in Cleveland, OH.

Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX.

Santé Capital Management LP (Santé) is an independent registered investment advisor and hedge fund manager headquartered in Austin, Texas. The firm was founded in 2016 by Kevin Lalande, Douglas French and Joe Cunningham. Santé serves as the investment manager and provides discretionary advisory services to certain private funds.

Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX.

Ketra, Inc. provides lighting solutions to retail, hospitality, and office spaces. Its products include luminaires, lamps, interfaces, controls and integration. The company was founded by Horace Ho and David J. Knapp in 2009 and is headquartered in Austin, TX.